Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Guru Sonpavde, M.B.,B.S.

Co-Author

This page shows the publications co-authored by Guru Sonpavde and Elio Adib.
Connection Strength

0.789
  1. Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin. Clin Genitourin Cancer. 2021 Aug 14.
    View in: PubMed
    Score: 0.245
  2. Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting Agent. Mol Cancer Ther. 2021 08; 20(8):1454-1461.
    View in: PubMed
    Score: 0.242
  3. CDKN2A Alterations and Response to Immunotherapy in Solid Tumors. Clin Cancer Res. 2021 Jul 15; 27(14):4025-4035.
    View in: PubMed
    Score: 0.242
  4. Trans-ethnic variation in germline variants of patients with renal cell carcinoma. Cell Rep. 2021 03 30; 34(13):108926.
    View in: PubMed
    Score: 0.060
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.